Clinical Outcomes and Characteristics of Chinese Patients with Type 2 Diabetes and Chronic Kidney Disease Initiating SGLT2 Inhibitors or GLP-1 Receptor Agonists: Insights from a Regional Real-World Cohort - Notícias Vera Health